Not There Yet: Medicare Part D and Elimination of Cardiovascular Medication Usage Socio-Demographic Disparities after Myocardial Infarction
In this issue of Circulation, Lauffenburger and colleagues examine the effect of Medicare Part D implementation on statin, beta-blocker and angiotensin-converting-enzyme inhibitor (ACEI)/angiotensin receptor blockers (ARB) medication usage based on race/ethnicity and gender in the United States1. The authors utilized Medicare service claims in 85,017 post-myocardial infarction (MI) patients, aged 65 years and older. Their primary findings are that African- American (black) women are 30% less likely to be adherent to ACEI/ARBs and statins at 1 year post-MI compared to white men. Additionally, women and black/Hispanic men had approximately 10% lower medication adherence rates compared to white men.
- Received December 2, 2013.
- Accepted December 6, 2013.